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Cruciferous vegetables, in particular those included into the Brassica genus, are good sources of a variety of nutrients
and health-promoting phytochemicals. Phenolic compounds are the major antioxidants of Brassica; hence the
contribution of Brassica vegetables to health improvement has largely been associated to their antioxidant capacity.
This study aimed to assess anti-diabetic, antilipidemic, and antioxidant activity of phenolic rich extract of Brassica
oleraceae var gongylodes (BOvG) in Wistar rats. The findings revealed that the administration of BOvG extract to diabetic
rats significantly reduced fasting blood glucose by 64% within 7 days of treatment. Additionally, BOvG extract was also
observed to normalize the diabetic rats’ lipid profile and HbA1c (Glycated hemoglobin). BOvG extract also showed
protection of liver- kidney functions, which was evidenced by the significant decrease in Blood Urea Nitrogen (BUN),
Serum glutamic oxaloacetic transaminase (SGOT) and Serum glutamic pyruvic transaminase (SGPT). The treatment also
improved the antioxidant status of the diabetic rats where the enzymatic activities of Catalase (CAT) and Super Oxide
Dismutase (SOD) were significantly increased. Furthermore, RP-HPLC analysis detected chlorogenic acid, rutin, and
sinapic acid against known standards in BOvG extract. Hence, the present investigation suggests that BOvG phenolic
rich extract (as a multi-component therapy) exhibited anti-diabetic, antilipidemic and antioxidant properties in STZ-
induced diabetic rats.
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In the last few decades, there has been a tremendous in-
crease in the prevalence of type 2 diabetes internationally,
and has been estimated that the number of diabetic patients
will be more than 205 million in the next 20 years (Diabetes
Atlas and 6th Edition 2014). Oral hypoglycemic agents and
insulin, generally used to treat Diabetes Mellitus (DM),
have number of serious side effects (Kyriacou and Ahmed
2010). Hence, interest has increased in finding naturally oc-
curring anti-diabetic therapeutics to replace synthetic drugs
(Velioglu et al. 1998). As there have been increasing em-
phasis on the promotion of a healthy diet for the manage-
ment of type 2 diabetes, there is a great necessity to* Correspondence: indumati_sharma@hotmail.com; prakashrnaik@yahoo.co.in
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in any medium, provided the original work is pinvestigate the combination of drugs derived from natural
resource extracts (Kaur et al. 2013).
Numerous studies have established an inverse correl-
ation between the intake of fruits and vegetables and the
onset of diseases such as diabetes, cardiovascular dis-
ease, cancer, and aging-related disorders as they are rich
source of dietary antioxidants, including polyphenolics,
vitamins E and C, and carotenoids (Huang et al. 2005).
Polyphenolic compounds, in particular, have been shown
to terminate free radical chain reactions in biological
systems, and hence can act as nutraceuticals for a range
of oxidative stress implicated diseases, like diabetes and
cancer (Espín et al. 2007).
Amongst plant foods with health benefits, crops from the
family Brassicaceae (also known as Cruciferae) have been
the focus of numerous epidemiological and clinical studies
(Podsędek 2007) as they are good source of variety ofan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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Soengas et al. 2011). Brassica vegetables, like knol khol,
cabbage, broccoli, cauliflower, kale and Brussels sprouts
are widely consumed throughout the world. Folklore
medicine have shown that knolkhol/kohlrabi, scientific-
ally known as Brassica oleraceae var gongylodes (BOvG)
has health promoting activity and anti-diabetic activity. Pre-
viously (Huchaiah et al. 2008) BOvG juice was assessed for
hypoglycemic activity and its related biochemical parame-
ters. However, till date phenolic rich extract of BOvG and
its components have not been investigated and hence the
present investigation assessed anti-diabetic activity of phen-
olic rich extract of BOvG.
Methodology
Induction of diabetes in rats
Wistar rats weighing 160 ± 15 g were housed in an animal
facility. The animals were acclimatized to the environment
(26 ± 5°C, 55 ± 10% relative humidity, and 12 h dark/light
cycle) for 1 week prior to experimental use. The rats were
fed with a standard laboratory diet (Amruth feeds Pvt.
Ltd, Bangalore) and water ad libitum. Ethical clearance
was obtained from Institutional Animal Ethics Committee
of Animal Research (IAEC approval number: UOM/
IAEC/09/2012) at DOS in Zoology, University of Mysore,
and experiments were carried out as per the guidelines of
the committee.
The animals were divided into 4 groups and each
group consisted of 5 rats:
– Group 1: Control- normal untreated rats (citrate
buffer injected)
– Group 2: Diabetic- STZ diabetic rats
– Group 3: BOvG800- STZ rats treated with BOvG
(800 mg/kg body weight)
– Group 4: Glibenclamide- STZ rats treated with
glibenclamide (1 mg/kg body weight)
Overnight fasted animals were made diabetic by intra-
peritoneal injection of freshly prepared streptozotocin in
citrate buffer (0.1 M, pH 4.5) at a dose of 47 mg/kg body
weight. The control rats were only injected with citrate
buffer. After 96 h of induction when blood glucose was
stabilized, fasting blood glucose (FBG) was determined
and rats having FBG >250 mg/dl were designated as hav-
ing diabetes mellitus and were used in this experiment.
The experimental period lasted for 28 days and day 0
was designated as the day when rats were confirmed to
be diabetic.
STZ untreated rats were left as such for the entire experi-
mental duration. BOvG extract was dissolved in distilled
water and was given orally once daily using an intra-gastric
gavage for 28 days for diabetic rats. Glibenclamide (1 mg/
body weight) was administered as positive control.Preparation of plant extract
The knob of BOvG was washed under running water
thoroughly, chopped into slices, dried in a hot air oven
at 45°C for 24 h, and powdered to 60 mesh in an apex
grinder. The powdered sample was then extracted seri-
ally using solvents with increasing polarity, namely, hex-
ane, ethyl acetate, and double distilled water at room
temperature (25°C), so as to extract both non-polar and
polar bioactive compounds. The extraction process was
repeated until the solvent became colorless. The extracts
were then filtered (Whatman No.1 filter paper) and
dried using a rotary evaporator (Hahnvapor, model no.
HS-2005S, Korea). The solvents in the poly phenolic rich
extract (or the aqueous extract) were allowed to evapor-
ate completely in a hot air oven at 32°C and the extract
was stored there until further use.
Determination of phenolic compounds
Analytical HPLC was carried out to determine the presence
of phenolic compounds in the BOvG extract (Francisco
et al. 2010). Briefly, the analysis was carried out on a Luna
C18; column (250 mm × 4.6 mm, 5 μm particle size;
Phenomenex, Macclesfield, UK). The mobile phase was
a mixture of: (A) HPLC grade water/trifluoro acetic
acid (TFA) (99.9:0.1) and (B) methanol/TFA (99.9:0.1).
The flow rate was 1 mL min-1 in a linear gradient start-
ing with 0% B at 0–5 mins, reaching 17% B at 15–17 min,
25% B at 22 mins, 35% B at 30 mins, 50% B at 35 mins,
99% B at 50 mins and at 55–65 mins 0% B. The injection
volume was 20 μl and chromatograms were recorded at
320 nm for phenolic derivatives. Polyphenolics were
identified by sinapic acid (Sigma-Aldrich), chlorogenic
acid (Sisco Research Laboratories Pvt. Ltd) and rutin
(Sigma-Aldrich,) as standards.
Fasting Blood Glucose (FBG)
The animals were fasted overnight and the blood from
tail vein was estimated for fasting blood glucose by gluc-
ometer (from Accu-Chek) in which its measurement
principle is based on glucose dehydrogenase method.
The blood glucose was measured on days 0, 7, 14, 21
and 28 days after treatment.
Biochemical parameters
All rats were anesthetized by diethyl ether after record-
ing the final body weight. The blood samples of each
animal were collected through cardiac puncture and
serum was obtained by centrifuging blood samples at
4000 rpm at 25°C for 4 min and analyzed for assorted
biochemical parameters. The obtained serum samples
was preserved at −20°C. The total cholesterol (TC), high
density lipoprotein (HDL) cholesterol, low density lipo-
protein (LDL) cholesterol, total triglyceride (TG), SGOT,
SGPT and BUN was done through Artos - Versatile
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plied by Swemed biomedicals pvt. ltd., India). Whole
blood was collected separately (preserved with anticoa-
gulating agents) for the estimation of glycosylated hemo-
globin using standard kits (supplied by Swemed biomedicals
pvt. ltd., India).
Estimation of antioxidant enzymes
Antioxidant enzyme was estimated by liver and kidney
homogenate (10% homogenate), prepared in chilled
phosphate buffer solution of pH 7.0. This was used to
measure the levels and activities of superoxide dismutase
(Marklund and Marklund 1974) and catalase (Sinha
1972) through standard protocols. SOD was assayed by
autoxidation of pyrogallol while CAT was assayed by de-
composition of hydrogen peroxide. The activities were
expressed as unit/mg of protein (a unit is defined as the
amount which will catalyse the transformation of 1 mi-
cromole of substrate (or product) per min, under de-
fined assay conditions).
Statistical analysis
All the data were expressed as the mean ± SEM and ana-
lysis of variance (ANOVA) was used for the statistical
analysis using SPSS 11.5 followed by Duncan Multiple
Range post hoc test. The values were considered to be
significant when p < 0.05.
Results
Effect of BOvG on body weight and on Fasting Blood
Glucose (FBG) level
Body weight of control groups increased over a period of
time and there was not much difference in weight gain
amongst the control groups at the end of the experimental
period (Figure 1). On the other hand there was loss of
body weight (by 24%) in the diabetic group. Upon treat-
ment with BOvG extract, BOvG800 group’s body weightFigure 1 Effect of BOvG extract on body weight.was similar to that of control group and was significantly
different (P < 0.05) from diabetic group. Glibenclamide
group showed increase in body weight (significantly differ-
ent from diabetic group, P < 0.05) but it did not equal that
of control (P < 0.05).
The fasting blood sugar (FBS) of control groups over the
course of 4 weeks was 99–113 mg/dl and was not signifi-
cantly (P > 0.05) different from one another (Figure 2). Dia-
betic groups showed steep increase in FBS and at the end
of 4th week the FBS was 420 mg/dl. Treatment with BOvG
extract, however, reduced the FBS in the first week to
98.5 mg/dl (by 64%) and was maintained as such for the en-
tire experimental period. BOvG group showed no signifi-
cant difference (P < 0.05) compared to control from week 1
to the end of week 4. Similarly glibenclamide group also
showed reduction in FBS to 180 mg/dl (by 42%) at the end
of 4th week. BOvG extract showed more potency for anti-
hyperglycemic activity than glibenclamide.Effect of BOvG on lipid profile
To evaluate the effect of BOvG extract on lipid profile
level, TC (total cholesterol), TG (triglyceride), LDL (low
density lipoprotein) and HDL (high density lipoprotein)
were assessed at the end of 4 weeks. Diabetic rats showed
an increase of 47.5% in LDL, 27% in TC, 46% in TG and a
61% decrease in HDL (Table 1). Diabetic rats were signifi-
cantly different from control (P < 0.05). BOvG800 group,
contrarily, showed restoration of LDL, HDL, TC and TG
to the levels of control rats as there was no significant
difference between BOvG800 group and control group. In
the glibenclamide group LDL, HDL and TG showed mar-
ginal restoration of lipid profile levels as it was still sig-
nificantly different to that of control group (P < 0.05).
However, TC of glibenclamide group showed full restor-
ation of the normal levels as it was not significantly dif-
ferent from control.
Figure 2 Effect of BOvG extract on plasma glucose levels.
Sharma et al. SpringerPlus  (2015) 4:212 Page 4 of 7Effect of BOvG extract on glycated hemoglobin (HbA1c)
The diabetic rats showed increased levels (32%) of HbA1c
and significantly (P < 0.05) differed to that of control group
(Table 2). The BOvG800 group showed decrease (43%) in
HbA1c levels and did not show significant difference to that
of control. Glibenclamide group too showed restoration of
HbA1c levels compared to control significantly (P < 0.05).
Effect of BOvG extract on serum biochemical markers:
Blood Urea Nitrogen (BUN), SGOT (Serum glutamic
oxaloacetic transaminase), SGPT (Serum glutamic pyruvic
transaminase)
The serum biomarkers, BUN, SGOT and SGPT, were esti-
mated for the assessment of kidney’s and liver’s physio-
logical function. BUN levels were significantly (P < 0.05)
increased (54.75%) in diabetic groups (Table 2), when com-
pared to control groups. The BOvG800 group were normal-
ised to that of control group’s levels. Glibenclamide group
also showed significant reduction in BUN levels compared
to diabetic group (P < 0.05).
The hepatic enzymes SGOT’s and SGPT’s levels in serum
increased significantly (P < 0.05) in diabetic groups by 47%
and 45% respectively, whereas the BOvG800 group’s SGOT
and SGPT showed a decrease by 45% and 39% respectively.
Glibenclamide groups also restored the SGOT and SGPT
levels to that of control group significantly (P < 0.05).Table 1 Effect of BOvG on lipid profile
Group LDL (mg/dL) HDL (mg/dL) TC (mg/dL) TG (mg/dL)
Control 42.60 ± 2.9a 41.20 ± 2.8a 73.80 ± 3.1a 81.3 ± 2.6a
Diabetic 80.37 ± 3.5c 16.70 ± 2.0c 100.50 ± 6.2b 152.03 ± 3.0c
BOvG800 43.35 ± 1.9
a 38.82 ± 2.4ba 74.27 ± 1.6a 90.34 ± 3.7a
Glibenclamide 51.33 ± 1.3b 32.92 ± 2.5b 78.97 ± 2.3a 115.26 ± 4.1b
Note. Values are mean ± SEM (n = 5). Means in the same columns with different
superscripts differ significantly (p < 0.05).Effect of BOvG on antioxidant enzymes- Superoxide
dismutase (SOD) and Catalase (CAT)
In diabetic group SOD and CAT activity was significantly
(P < 0.05) decreased (Table 3). Liver’s and Kidneys’ SOD in
diabetic group showed significant (P < 0.05) decrease by
54% and by 42% respectively. However the enzymatic activ-
ity was restored in BOvG800 and glibenclamide groups and
was not significantly different from control.
Catalase activity in diabetic group’s kidney was signifi-
cantly (P < 0.05) reduced (Table 3). It was observed that
kidneys CAT activity (reduction by 62%) was reduced twice
as that of liver (reduction by 34%) in diabetic groups.
Contrarily, CAT activity was restored in BOvG800 group
where they showed an increase by 21% in liver and 47%
in kidneys, was not significantly different from control.
Glibenclamide group was also able to restore CAT ac-
tivity, but was not as potent as BOvG800 group where it
was significantly different from control in both liver
and kidney.Detection of polyphenolics
The major polyphenolic present in BOvG were recognized
by comparison to the retention times and absorption spec-
tra of authentic standard markers. Retention times for
chlorogenic acid, sinapic acid and rutin were 30.83, 38.55,Table 2 Effect of BOvG on serum biochemical markers
Group BUN (mg/dl) SGPT (Iu/L) SGOT (Iu/L) HbA1c (%)
Control 6.98 ± 0.4bc 6.90 ± 0.4bc 76.36 ± 2.1c 76.10 ± 1.5c
Diabetic 3.20 ± 0.4a 4.01 ± 0.3a 50.25 ± 4.6a 29.50 ± 2.2a
BOvG800 7.56 ± 0.5
c 7.43 ± 0.3c 71.25 ± 1.3bc 72.00 ± 1.3c
Glibenclamide 6.19 ± 0.4b 6.28 ± 0.3b 66.75 ± 1.7b 63.50 ± 0.7b
Note. Values are mean ± SEM (n = 5). Means in the same columns with different
superscripts differ significantly (p < 0.05).
Table 3 Effect of BOvG on antioxidant enzymes in liver
and kidney
Groups SOD liver
(U/mg of
protein)
SOD kidney
(U/mg of
protein)
CAT liver
(U/mg of
protein)
CAT kidney
(U/mg of
protein)
Control 42.35 ± 2.3a 34.43 ± 1.4a 42.05 ± 1.3a 5.50 ± 0.2a
Diabetic 93.89 ± 4.9b 62.99 ± 2.0b 79.20 ± 3.3b 8.10 ± 1.1b
BOvG800 41.26 ± 3.7
a 39.38 ± 1.2a 43.70 ± 1.9a 4.59 ± 0.3a
Glibenclamide 45.41 ± 4.1a 38.08 ± 2.7a 53.29 ± 3.6a 5.21 ± 0.2a
Note. Values are mean ± SEM (n = 5). Means in the same columns with different
superscripts differ significantly (p < 0.05).
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g and 1.6 mg/g respectively (Figure 3).
Discussion
Diabetes is a metabolic disorder of carbohydrate, fat and
protein, affecting a large number of populations in the
world. The pathogenesis of diabetes involving hypergly-
cemia, dysregulated metabolism and the ensuing diabetes
specific micro as well as macro vascular complications have
posed an immense challenge for its overall treatment.
Most modern drug discovery has been based on a
‘one-disease–one-target–one-drug' strategy (Ji et al.
2009). A multifactorial disease like diabetes requires a
combination of different types of nutraceuticals that
target multiple pathways rather than a selective com-
pound which often target a single pathway. This ‘multi-
component therapeutics’ is gaining huge popularity
within the scientific community (Ji et al. 2009), and it is
imperative that the pharmaceutical industry realize itsFigure 3 RPHPLC fingerprint chromatogram of BOvG extract and the strucimportance to overcome the challenge of ‘more invest-
ment, fewer drugs'.
The polyphenols in Brassica vegetables have immense
health improvement potential as these polyphenols have
high antioxidant activity (Cartea et al. 2011). Rasal et al.
(2005) demonstrated the anti-diabetic and anti-oxidant ac-
tivities of petroleum extract of knol khol in diabetic rats.
The phenolic rich extract in the present study fared better
than the petroleum extract, as it achieved euglycemia
within one week of treatment. In this study, we have also
identified the presence chlorogenic acid (5.9 mg/g), sinapic
acid (2.7 mg/g) and rutin (1.6 mg/g) in BOvG. Earlier,
chlorogenic acid and its isomers, neo- and cryptochloro-
genic acids have been reported in other Brassica species
and have been the important predictors for antioxidative
capacity in Brassica varieties (Kaulmann et al. 2014).
The most abundant group of polyphenols in Brassica spe-
cies are the flavonoids and hydroxycinnamic acids (Cartea
et al. 2011). Significant levels of chlorogenic acids have pre-
viously been reported in leafy Brassica species, like kale,
cabbage and Brussels sprouts. Earlier reports have found
flavonoid glycosides, hydroxycinnamic acids as well as sina-
pic acids and their derivatives to be the most predominant
phenolics in Brassica sps. (Cartea et al. 2011). In addition to
polyphenolics, isothiocynates (hydrolytic products of gluco-
sinolates; a characteristic compound in Brassica), have been
identified in early white vienna cultivar of BOvG with
4-methylthiobutyl being the most predominant isothio-
cynate (Carlson et al. 1987).
In the present investigation, on treating diabetic rats
with BOvG extracts, the FBG levels normalized withintures of polyphenols identified.
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enclamide. This anti-diabetic activity of BOvG extract
was possibly attributed to the additive effect of activa-
tion of a number of molecular pathways by the various
enriched bioactive components. Earlier reports have
shown chlorogenic acid stimulates glucose transport in
skeletal muscle via the activation of AMPK (Ong et al.
2012) and sinapic acid activates PLC-PKC signals to en-
hance the glucose utilization GLUT4 in muscle cells
(Cherng et al. 2013). Additionally, chlorogenic acid and
rutin have shown cholesterol lowering abilities by up-
regulating the Gene Expression of PPAR-α (Wan et al.
2013) and by ameliorating oxidative stress genes (Al-Rejaie
et al. 2013) respectively.
There are various studies in which different herbal
drug combinations have been beneficial for reducing
dosage, side effects and the duration of action (Kaur
et al. 2013; Rathera et al. 2013). Herbal drugs also have
additive effects; thus showing drastic reduction in FBG
levels and amelioration of diabetic related complications
in BOvG fed rats in this study. In continuation of this
study, the combination index of chlorogenic acid, sinapic
acid and rutin (the predominant polyphenols found in
BOvG) (Rathera et al. 2013; Chou 2006) and the nature
of their interactions, needs to be further investigated in
a diabetic model.
BOvG has shown in this study and earlier studies
(Huchaiah et al. 2008; Rasal et al. 2005) immense poten-
tial as a natural alternative to control diabetes. In the
short run, BOvG tuber can be an important part of meal
planning for diabetic patients in order to manage their
post prandial blood glucose level. Moreover, in the lon-
ger run, compounds identified in BOvG have the poten-
tial to be developed as natural anti-diabetic drugs.Conclusion
Based on our current findings BOvG significantly reduced
FBG to normal levels and alleviated diabetes related com-
plications. We suggest that the phytomolecules in BOvG
have the potential to form a multi-component drug to tar-
get diabetes and its related complications.Animal rights
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